High-Sensitivity C-Reactive Protein is a Predictor of In-Hospital Cardiac Events in Acute Myocardial Infarction Independently of GRACE Risk Score

No abstract is available for this paper.

• Publication year

  2012

• Venue

  Angiology

• Publication date

  2012-01-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1177/0003319711406502PMID 21555309
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Contrast-Induced Nephropathy and the Vascular Patient

  2010cited by this paper
• Early Diagnostic Markers for Contrast Nephropathy in Patients Undergoing Coronary Angiography

  2010cited by this paper
• C-reactive protein: risk factor, biomarker and/or therapeutic target?

  2010cited by this paper
• Efficacy of short-term high-dose atorvastatin for prevention of contrast-induced nephropathy in patients undergoing coronary angiography.

  2010cited by this paper
• Prognostic implications of C-reactive protein and troponin following percutaneous coronary intervention.

  2009cited by this paper
• [Management of acute myocardial infarction in patients presenting with persistent ST-segment elevation].

  2009cited by this paper
• MANAGEMENT OF ACUTE MYOCARDIAL INFARCTION IN PATIENTS PRESENTING WITH PERSISTENT ST-SEGMENT ELEVATION (ENDING)

  2009cited by this paper
• Joint ESC/ACCF/AHA/WHF Task Force for the Redefinition of Myocardial Infarction

  2008cited by this paper
• Differential impact of admission C-reactive protein levels on 28-day mortality risk in patients with ST-elevation versus non-ST-elevation myocardial infarction (from the Monitoring Trends and Determinants on Cardiovascular Diseases [MONICA]/Cooperative Health Research in the Region of Augsburg [KORA

  2008cited by this paper
• Management of acute myocardial infarction in patients presenting with persistent ST-segment elevation: the Task Force on the Management of ST-Segment Elevation Acute Myocardial Infarction of the European Society of Cardiology.

  2008cited by this paper
• Universal definition of myocardial infarction.

  2007cited by this paper
• C-reactive protein and heart failure after myocardial infarction in the community.

  2007cited by this paper
• C-reactive protein and the prediction of cardiovascular events among those at intermediate risk: moving an inflammatory hypothesis toward consensus.

  2007influential reference
• Guidelines for the diagnosis and treatment of non-ST-segment elevation acute coronary syndromes.

  2007cited by this paper
• Universal definition of myocardial infarction.

  2007cited by this paper
• [Guidelines for the diagnosis and treatment of non-ST-segment elevation acute coronary syndromes].

  2007cited by this paper
• [Kinetics of C-reactive protein release in different forms of acute coronary syndrome].

  2006cited by this paper
• Cinética de la proteína C reactiva en las distintas manifestaciones clínicas del síndrome coronario agudo

  2006cited by this paper
• Clinical Relevance of C-Reactive Protein During Follow-Up of Patients With Acute Coronary Syndromes in the Aggrastat-to-Zocor Trial

  2006cited by this paper
• Association of inflammatory biomarkers and cardiac troponin I with multifocal activation of coronary artery tree in the setting of non-ST-elevation acute myocardial infarction.

  2005cited by this paper
• Markers of Inflammation and Rapid Coronary Artery Disease Progression in Patients With Stable Angina Pectoris

  2004cited by this paper
• Effect of tirofiban on C-reactive protein in non-ST-elevation myocardial infarction.

  2004cited by this paper
• Predictors of hospital mortality in the global registry of acute coronary events.

  2003cited by this paper
• Markers of inflammation and cardiovascular disease: application to clinical and public health practice: A statement for healthcare professionals from the Centers for Disease Control and Prevention and the American Heart Association.

  2003cited by this paper
• MARKERS OF INFLAMMATION AND CARDIOVASCULAR DISEASE: APPLICATION TO CLINICAL AND PUBLIC HEALTH PRACTICE: A STATEMENT FOR HEALTHCARE PROFESSIONALS FROM THE CENTERS FOR DISEASE CONTROL AND PREVENTION AND THE AMERICAN HEART ASSOCIATION

  2003cited by this paper
• Inflammation and Atherosclerosis

  2002cited by this paper
• Systemic inflammation in unstable angina is the result of myocardial necrosis.

  2002cited by this paper
• Usefulness of high-sensitivity C-reactive protein in predicting long-term risk of death or acute myocardial infarction in patients with unstable or stable angina pectoris or acute myocardial infarction.

  2002cited by this paper
• Inflammation and atherosclerosis: here, there, or everywhere.

  2001cited by this paper
• Markers of myocardial damage and inflammation in relation to long-term mortality in unstable coronary artery disease. FRISC Study Group. Fragmin during Instability in Coronary Artery Disease.

  2000cited by this paper
• Independent prognostic value of C-reactive protein and troponin I in patients with unstable angina or non-Q-wave myocardial infarction.

  1999cited by this paper
• Prognostic influence of increased fibrinogen and C-reactive protein levels in unstable coronary artery disease. FRISC Study Group. Fragmin during Instability in Coronary Artery Disease.

  1997cited by this paper
• The prognostic value of C-reactive protein and serum amyloid a protein in severe unstable angina.

  1994cited by this paper

• Clinical, economic, and health care resource utilization burden of acute myocardial infarction and the role of systemic inflammation in US hospitals: A real-world study

  2025cites this paper
• Wearable biosensors for monitoring and as a predictive adjunct for patients at risk for ischemic cardiac‐related injury

  2025cites this paper
• HDL or hs-CRP: The Prognostic Conundrum in Acute Coronary Syndrome

  2024cites this paper
• Prognostic Implications of Clinical, Laboratory and Echocardiographic Biomarkers in Patients with Acute Myocardial Infarction—Rationale and Design of the ‘‘CLEAR-AMI Study’’

  2023cites this paper
• Correlation of hs-CRP with in-hospital Outcome of Patients with Acute Coronary Syndrome (ACS)

  2022cites this paper
• High-Sensitivity C-Reactive Protein-to-Albumin Ratio in Predicting the Major Adverse Cardiovascular Event in Acute Coronary Syndrome at Presentation

  2022cites this paper
• Fibroblast activation protein imaging in reperfused ST-elevation myocardial infarction: comparison with cardiac magnetic resonance imaging

  2021cites this paper
• Clinical Risk Prediction Models for the Prognosis and Management of Acute Coronary Syndromes.

  2021cites this paper
• Changes in the lipid profile after acute myocardial infarction at the stage of outpatient follow-up

  2020cites this paper
• The prognostic role of high-sensitivity C-reactive protein in patients with acute myocardial infarction

  2020cites this paper
• Contrast‐induced nephropathy is associated with new‐onset atrial fibrillation in acute coronary syndrome after cardiac catheterization: Systemic review and meta‐analysis

  2019cites this paper
• The Glasgow prognostic score as a significant predictor of clinical outcomes in patients with acute coronary syndrome.

  2019cites this paper
• Prognostic efficacy of high-sensitivity C-reactive protein to albumin ratio in patients with acute coronary syndrome.

  2019cites this paper
• C-reactive Protein is a Predictor of Mortality in ST-segment Elevation Acute Myocardial Infarction

  2018cites this paper
• Fibrinogen is related to long-term mortality in Chinese patients with acute coronary syndrome but failed to enhance the prognostic value of the GRACE score

  2017cites this paper
• Prognostic value of plasma biomarkers in patients with acute coronary syndrome: a review of advances in the past decade.

  2016cites this paper
• Lower mean corpuscular hemoglobin concentration is associated with poorer outcomes in intensive care unit admitted patients with acute myocardial infarction.

  2016cites this paper
• Correlations between severity of coronary atherosclerosis and persistent elevation of circulating C-reactive protein levels 30 days after an acute myocardial infarction

  2014cites this paper
• The value of C-reactive protein in emergency medicine

  2014cites this paper
• Predictive value of GRACE risk scores for contrast-induced acute kidney injury in patients with ST-segment elevation myocardial infarction before undergoing primary percutaneous coronary intervention

  2014cites this paper
• The Impact of Ischemic Time on the Predictive Value of High-Sensitivity C-Reactive Protein in ST-Segment Elevation Myocardial Infarction Patients Treated by Primary Percutaneous Coronary Intervention

  2013cites this paper
• Myeloperoxidase and C-reactive protein in patients with cocaine-associated chest pain.

  2013cites this paper
• High-sensitivity C-reactive protein predicts adverse outcomes after non-ST-segment elevation acute coronary syndrome regardless of GRACE risk score, but not after ST-segment elevation myocardial infarction.

  2013cites this paper
• Relationship between serum level of high-sensitive C-reactive protein and extension of myocardial involvement in patients with acute myocardial infarction.

  2012cites this paper
• Study of C-Reactive Protein and Myocardial Infarction in the Indian Population

  2011cites this paper